Promis Neurosciences (PMN) has been working on a treatment and more recently a vaccine for Alzheimer's Disease.
They've recently submitted an NDA to the FDA for their lead candidate, PMN310.
Stock price has really shot up in the last week. I'm of the opinion that's it's due to an impending approval of their NDA. Others think a partnership/buyout via Big Pharma may be in the works.
I've been holding this stock since around 2017, and it may finally be ready to pay off.
Would love to hear other's opinions on it.
Leave a Reply